Harmony Biosciences Holdings, I
HRMY
Jodie situation report
Harmony Biosciences Holdings, I's current read is isolated; its market group is not confirming.
No new filing conclusion is available. 0 of 1 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 7 directly disclosed connections are confirming.
- HRMY's market-adjusted activity becomes unusual and at least one connected name confirms.
Invalidation: The isolated read changes if HRMY's group or a disclosed connection begins moving with it.
Who this business touches
The relationships behind HRMY
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
ALKSAlkermes plcsupplierFeb 24, 2026 ▾
“Additionally, Avadel Pharmaceuticals (acquired by Alkermes Plc in February 2026) launched a once nightly formulation version of sodium oxybate in June 2023.”
JPMJP Morgan Chase & Co.lenderMay 7, 2026 ▾
“Term Loan A Credit Agreement In July 2023, we entered into a Credit Agreement (the “TLA Credit Agreement”) with JPMorgan Chase Bank, N.A., as “Administrative Agent”, and certain lenders, which was subsequently amended in September 2023.”
Depended on by
AXSMAxsome Therapeutics, Inc.competitorFeb 23, 2026 ▾
“15 Table of Contents AXS‑12 Competition Products approved to treat the symptoms of narcolepsy include generic and/or branded forms of Ritalin, the branded form of which is marketed by Novartis Pharmaceuticals; Provigil and Nuvigil, which are both marketed by…”
Filing peers
Companies whose filings use similar operating language.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 6 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
HRMY is currently a Leader in the organic co-movement group Rare Neurological Therapies. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.
This group is retained as the last observed read for HRMY; it is not active in the latest market snapshot.